Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

INOMAX DIN 02572656

Status: Approved
Holder: INO THERAPEUTICS
Molecule: NITRIC OXIDE

Health Canada record

Active ingredient(s)NITRIC OXIDE 4880 PPM
Dosage formGas
RouteInhalation
SchedulePRESCRIPTION
ClassHuman
ATCR07AX01 NITRIC OXIDE
Original market date
Current status date15-Oct-2026
SourceHealth Canada DPD

Establishment licence of the holder

INO Therapeutics, LLC. — licence , not currently licensed, last inspection rating C (2015-05-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NITRIC OXIDE

DINProductCompanyFormStrengthStatus
02270846INOMAXINO THERAPEUTICSGasNITRIC OXIDE 800 PPMMarketed
02451328KINOXAIRGAS THERAPEUTICS LLCGasNITRIC OXIDE 800 PPMMarketed
02270838INOMAXINO THERAPEUTICSGasNITRIC OXIDE 100 PPMCancelled Post Market
02451301KINOXAIRGAS THERAPEUTICS LLCGasNITRIC OXIDE 100 PPMDormant
02451417NOXIVENTPRAXAIR CANADA INCGasNITRIC OXIDE 100 PPMCancelled Post Market
02451425NOXIVENTPRAXAIR CANADA INCGasNITRIC OXIDE 800 PPMCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
384772026-10-15Supplement to a New Drug Submission (SNDS)Addition of new strength: 4880 ppm. New package labels

International API supply for NITRIC OXIDE

2 valid EDQM Certificates of Suitability from 2 holders. 1 active FDA Drug Master Files.

Request a quote for INOMAX

How to read a Canadian DIN record